Centauri
immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic areas
London, UKwww.centauritherapeutics.com ↗
Total raised
€39M
€38,779,535
Funding rounds
2
Investors
3
distinct backers
Active since
2025-07
latest 2026-02
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood11
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▼ Young (<3y)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-24 | Series A | €34M | Other investors,The AMR Action Fund | View deal → |
| 2025-07-29 | Other | €4.4M | Carb-X | View deal → |